chr2-197487154-CAG-C
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_002156.5(HSPD1):c.1612_1613delCT(p.Leu538ValfsTer13) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002156.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSPD1 | NM_002156.5 | c.1612_1613delCT | p.Leu538ValfsTer13 | frameshift_variant | Exon 12 of 12 | ENST00000388968.8 | NP_002147.2 | |
HSPD1 | NM_199440.2 | c.1612_1613delCT | p.Leu538ValfsTer13 | frameshift_variant | Exon 12 of 12 | NP_955472.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248780Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135210
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
HSPD1-related disorder Uncertain:1
The HSPD1 c.1612_1613delCT variant is predicted to result in a frameshift and premature protein termination (p.Leu538Valfs*13). To our knowledge, this variant has not been reported in the literature. Loss of function is not an established mechanism of HSPD1-related disease. This variant is reported in 0.00089% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-198351878-CAG-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at